SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005624
Filing Date
2017-08-01
Accepted
2017-08-01 17:09:22
Documents
44
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20170630x10q.htm 10-Q 972569
2 EX-10.1 mrns-20170630ex1018f2fcc.htm EX-10.1 118064
3 EX-31.1 mrns-20170630ex31184b023.htm EX-31.1 15231
4 EX-31.2 mrns-20170630ex31294007c.htm EX-31.2 15374
5 EX-32.1 mrns-20170630ex321f1258f.htm EX-32.1 9464
6 GRAPHIC mrns20170630x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-17-005624.txt   2908526

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20170630.xml EX-101.INS 427834
8 EX-101.SCH mrns-20170630.xsd EX-101.SCH 18684
9 EX-101.CAL mrns-20170630_cal.xml EX-101.CAL 24381
10 EX-101.DEF mrns-20170630_def.xml EX-101.DEF 57838
11 EX-101.LAB mrns-20170630_lab.xml EX-101.LAB 199822
12 EX-101.PRE mrns-20170630_pre.xml EX-101.PRE 136876
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 17997475
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences